TABLE 7.
Local Tolerability: Pain (Healthy Subjects)
| Variable | IgPro16 (15 mL) | IgPro20 (15 mL) | IgPro20 (12 mL) | Vivaglobin® (15 mL) |
|---|---|---|---|---|
| Subjects treated* | 28 (100%) | 28 (100%) | 28 (100%) | 28 (100%) |
| Maximum pain† (mm), mean (SD) | 6.8 (12.52) | 7.6 (12.46) | 6.9 (12.13) | 9.3 (14.18) |
| Mean pain† (mm), mean (SD) | 2.36 (5.029) | 2.84 (3.612) | 2.24 (4.240) | 3.78 (7.244) |
*
Results represent number of subjects (%).
†
Pain was assessed by subjects on a 100-mm VAS; numbers given are from that scale.
Source: Adapted from Hagan 2010.